Quanterix (QTRX) Net Cash Flow Growth (3y) (2020 - 2026)
Powered by 
Analysis
Quanterix (QTRX) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -35.32% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 50.05% |
| 10 | Quanterix | 124.99 Mn | 31.46 Mn | 12.67 Mn | 181.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181.08% |
| Mar 31, 2026 | 38.88% |
| Dec 31, 2025 | -19.71% |
| Sep 30, 2025 | -73.22% |
| Jun 30, 2025 | 85.41% |
| Mar 31, 2025 | 42.25% |
| Dec 31, 2024 | 60.64% |
| Sep 30, 2024 | 3.15% |
| Jun 30, 2024 | 28.91% |
| Mar 31, 2024 | -35.58% |
| Dec 31, 2023 | -74.53% |
| Sep 30, 2023 | -52.08% |
| Jun 30, 2023 | 26.96% |
| Mar 31, 2023 | 9.62% |
| Dec 31, 2022 | -4.51% |
| Sep 30, 2022 | -34.57% |
| Jun 30, 2022 | -32.67% |
| Mar 31, 2022 | -27.41% |
| Dec 31, 2021 | -23.30% |
| Sep 30, 2021 | -35.10% |